Related Experiment Video
Updated: Aug 8, 2026

Making Record-efficiency SnS Solar Cells by Thermal Evaporation and Atomic Layer Deposition
Published on: May 22, 2015
PROVE-IT proves that lower is better: a contrary view
1Centre for the Analysis of Cost-Effective Care and the Division of General Internal Medicine, The Montreal General Hospital, Montreal, Quebec. steven.grover@mcgill.ca
Insights
Lowering low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) together improves cardiovascular outcomes more than lowering LDL alone. Statins show varied effects on CRP, influencing overall cardiovascular benefit.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) are established independent risk factors for cardiovascular events.
- Statin therapy, primarily for lipid modification, exhibits pleiotropic effects, including CRP reduction.
Discussion:
- Conflicting results from recent clinical trials on intensive LDL lowering highlight the importance of pleiotropic effects.
- Specific statins' differential impact on CRP concentrations may significantly influence observed therapeutic benefits.
Key Insights:
- Lowering both LDL cholesterol and CRP offers superior cardiovascular protection compared to LDL reduction alone.
- The pleiotropic effects of statins, particularly on CRP, are crucial determinants of their efficacy in preventing cardiovascular events.
Outlook:
- Future cardiovascular event prevention strategies should consider targeting both LDL cholesterol and CRP.
- Further research into statin-specific pleiotropic mechanisms could optimize cardiovascular risk management.
Abstract:
Epidemiological studies have demonstrated that low density lipoprotein (LDL) cholesterol and C-reactive protein (CRP) are both independent risk factors for future cardiovascular events. Statin therapy, initially developed to modify blood lipid concentrations, has also been shown to have potentially important pleiotropic effects, including a reduction in CRP concentrations. Recent clinical trials have demonstrated conflicting results regarding the benefits associated with intensively lowering LDL cholesterol. An analysis of these results suggests that the different effects of specific statins on CRP concentrations may be an important determinant of the observed overall benefit associated with therapy. These studies together prove that while lowering LDL is beneficial, lowering LDL and CRP is better.
Related Concept Videos
Regression Toward the Mean
Confirmation Biases
Null and Alternative Hypotheses
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the population that is...
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
Bonferroni Test
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...

